{"id":558531,"date":"2025-01-22T10:09:24","date_gmt":"2025-01-22T02:09:24","guid":{"rendered":"https:\/\/law.asia\/?p=558531"},"modified":"2025-08-25T11:02:53","modified_gmt":"2025-08-25T03:02:53","slug":"pharmaceutical-ip-licensing","status":"publish","type":"post","link":"https:\/\/law.asia\/zh-hans\/pharmaceutical-ip-licensing\/","title":{"rendered":"\u533b\u836f\u8de8\u5883BD\u4ea4\u6613\u4e4b\u77e5\u4ea7\u8bb8\u53ef\u8981\u70b9"},"content":{"rendered":"<p style=\"text-align: justify;\">\u533b\u836f\u4f01\u4e1a\u8de8\u5883\u5546\u52a1\u62d3\u5c55\uff08BD\uff09\u4ea4\u6613\u4e3b\u8981\u6307\u533b\u836f\u4f01\u4e1a\u901a\u8fc7\u6280\u672f\u8bb8\u53ef\u8fdb\u884c\u8d44\u6e90\u6574\u5408\uff0c\u5b9e\u73b0\u4e1a\u52a1\u62d3\u5c55\uff0c\u5305\u62ec\u5bf9\u5916\u8bb8\u53ef\u548c\u5f15\u8fdb\u533b\u836f\u6280\u672f\u3002\u8fd9\u7c7b\u4ea4\u6613\u672c\u8d28\u4e3a\u77e5\u8bc6\u4ea7\u6743\u8bb8\u53ef\u4ea4\u6613\uff0c\u5728\u4ea4\u6613\u8fc7\u7a0b\u4e2d\u5e94\u91cd\u89c6\u76f8\u5173\u6cd5\u5f8b\u98ce\u9669\u3002<\/p>\n<h2 style=\"text-align: justify;\"><span class=\"vantage-red\"><strong>\u77e5\u4ea7\u5c3d\u8c03<\/strong><\/span><\/h2>\n<p style=\"text-align: justify;\">\u77e5\u8bc6\u4ea7\u6743\u5c3d\u804c\u8c03\u67e5\u662f\u4e3a\u89c4\u907f\u77e5\u8bc6\u4ea7\u6743\u6cd5\u5f8b\u98ce\u9669\u5fc5\u4e0d\u53ef\u5c11\u7684\u6807\u51c6\u73af\u8282\uff0c\u4e3b\u8981\u5305\u62ec\u5bf9\u533b\u836f\u6280\u672f\u77e5\u8bc6\u4ea7\u6743\u57fa\u672c\u60c5\u51b5\u3001\u4e13\u5229\u4fb5\u6743\u98ce\u9669\u3001\u77e5\u8bc6\u4ea7\u6743\u76f8\u5173\u91cd\u5927\u534f\u8bae\u8fdb\u884c\u8c03\u67e5\u4e0e\u5206\u6790\u3002<\/p>\n<h2 style=\"text-align: justify;\"><span class=\"vantage-red\"><strong>\u77e5\u4ea7\u72b6\u6001\u8c03\u67e5<\/strong><\/span><\/h2>\n<figure id=\"attachment_558518\" aria-describedby=\"caption-attachment-558518\" style=\"width: 200px\" class=\"wp-caption alignright\"><img class=\"wp-image-558518 size-full\" src=\"https:\/\/law.asia\/wp-content\/uploads\/2025\/01\/LI-HONGMEI.png\" alt=\"Li Hongmei\" width=\"200\" height=\"250\" \/><figcaption id=\"caption-attachment-558518\" class=\"wp-caption-text\"><strong>\u674e\u7ea2\u6885<\/strong> <br \/>\u5408\u4f19\u4eba<br \/>\u5e7f\u4fe1\u541b\u8fbe\u5f8b\u5e08\u4e8b\u52a1\u6240<\/figcaption><\/figure>\n<p style=\"text-align: justify;\">\u5e38\u89c4\u7684\u77e5\u8bc6\u4ea7\u6743\u5c3d\u804c\u8c03\u67e5\u4e3b\u8981\u6307\u5bf9\u77e5\u8bc6\u4ea7\u6743\u72b6\u6001\u8fdb\u884c\u5c3d\u804c\u8c03\u67e5\uff0c\u5305\u62ec\u5bf9\u5176\u5185\u5bb9\u3001\u767b\u8bb0\u72b6\u6001\u3001\u671f\u9650\u3001\u6743\u5c5e\u7b49\u8fdb\u884c\u8c03\u67e5\u5206\u6790\u3002<\/p>\n<p style=\"text-align: justify;\">\u4e13\u5229\u671f\u9650\u8c03\u6574\u5236\u5ea6\uff08PTA\uff09\u3001\u836f\u54c1\u4e13\u5229\u6743\u671f\u9650\u5ef6\u957f\u5236\u5ea6\uff08PTE\uff09\u4ee5\u53ca\u671f\u672b\u653e\u5f03\u5236\u5ea6\uff08TD\uff09\u5747\u53ef\u80fd\u5f71\u54cd\u77e5\u8bc6\u4ea7\u6743\u7684\u6709\u6548\u671f\u9650\u3002\u5728\u5c3d\u804c\u8c03\u67e5\u4e2d\uff0c\u4f01\u4e1a\u5e94\u67e5\u8be2\u76f8\u5e94\u6cd5\u5f8b\u89c4\u5b9a\u4ee5\u660e\u786e\u77e5\u8bc6\u4ea7\u6743\u7684\u6709\u6548\u671f\u9650\u3002PTA\u5236\u5ea6\u65e8\u5728\u8865\u507f\u4e13\u5229\u6388\u6743\u8fc7\u7a0b\u4e2d\u7684\u4e0d\u5408\u7406\u5ef6\u8fdf\uff1bPTE\u5236\u5ea6\u4e3b\u8981\u7528\u4e8e\u8865\u507f\u65b0\u836f\u4e0a\u5e02\u5ba1\u8bc4\u5ba1\u6279\u5360\u7528\u7684\u65f6\u95f4\uff1b\u800cTD\u5236\u5ea6\u5219\u662f\u7f8e\u56fd\u4e3a\u9632\u6b62\u7533\u8bf7\u4eba\u5c31\u540c\u4e00\u4e3b\u9898\u7684\u53d1\u660e\u4e0d\u65ad\u901a\u8fc7\u7533\u8bf7\u5ef6\u957f\u4e13\u5229\u4fdd\u62a4\u671f\u9650\uff0c\u4ece\u800c\u5bfc\u81f4\u91cd\u590d\u6388\u6743\u7684\u5236\u5ea6\u3002<\/p>\n<p style=\"text-align: justify;\">\u5728\u8fdb\u884c\u77e5\u8bc6\u4ea7\u6743\u6743\u5c5e\u7684\u5c3d\u804c\u8c03\u67e5\u65f6\uff0c\u4f01\u4e1a\u5e94\u5173\u6ce8\u8be5\u77e5\u8bc6\u4ea7\u6743\u662f\u5426\u4e3a\u8bb8\u53ef\u65b9\u81ea\u4e3b\u7814\u53d1\uff0c\u662f\u5426\u5b58\u5728\u8bb8\u53ef\u65b9\u4e0e\u7b2c\u4e09\u65b9\u5408\u4f5c\u7814\u53d1\u6216\u59d4\u6258\u7b2c\u4e09\u65b9\u7814\u53d1\u7684\u60c5\u51b5\u3002\u5982\u5b58\u5728\u5408\u4f5c\u7814\u53d1\u6216\u59d4\u6258\u7814\u53d1\u7684\u60c5\u51b5\u5219\u9700\u8981\u5ba1\u67e5\u8bb8\u53ef\u65b9\u4e0e\u7b2c\u4e09\u65b9\u7684\u534f\u8bae\uff0c\u4ee5\u660e\u786e\u77e5\u8bc6\u4ea7\u6743\u7684\u6743\u5c5e\u3002\u6b64\u5916\uff0c\u82e5\u77e5\u8bc6\u4ea7\u6743\u5c5e\u4e8e\u804c\u52a1\u53d1\u660e\u521b\u9020\uff0c\u8fd8\u5e94\u5bf9\u7814\u53d1\u4eba\u5458\u7684\u4efb\u804c\u60c5\u51b5\u8fdb\u884c\u5c3d\u804c\u8c03\u67e5\u3002<\/p>\n<h2 style=\"text-align: justify;\"><span class=\"vantage-red\"><strong>\u81ea\u7531\u5b9e\u65bd\u5206\u6790<\/strong><\/span><\/h2>\n<p style=\"text-align: justify;\">\u81ea\u7531\u5b9e\u65bd\u5206\u6790\uff08FTO\uff09\u65e8\u5728\u5224\u65ad\u4e00\u9879\u6280\u672f\u662f\u5426\u53ef\u4ee5\u5728\u4e0d\u4fb5\u72af\u4ed6\u4eba\u4e13\u5229\u6743\u7684\u524d\u63d0\u4e0b\u81ea\u7531\u4f7f\u7528\u3001\u5f00\u53d1\uff0c\u5e76\u5c06\u5176\u4ea7\u751f\u7684\u6210\u679c\u63a8\u5411\u5e02\u573a\u3002FTO\u5206\u6790\u601d\u8def\u4e3b\u8981\u662f\uff1a\u9996\u5148\uff0c\u7406\u89e3\u77e5\u4ea7\u76f8\u5173\u6280\u672f\u80cc\u666f\uff0c\u7136\u540e\u5c06\u6280\u672f\u62c6\u5206\u4e3a\u4e0d\u540c\u7684\u6280\u672f\u70b9\uff0c\u63a5\u7740\u5bf9\u5404\u6280\u672f\u70b9\u8fdb\u884c\u4e13\u5229\u68c0\u7d22\u548c\u5206\u6790\uff0c\u6700\u540e\u8fdb\u884c\u4fb5\u6743\u98ce\u9669\u8bc4\u4f30\u3002<\/p>\n<h2 style=\"text-align: justify;\"><span class=\"vantage-red\"><strong>\u7a33\u5b9a\u6027\u5206\u6790<\/strong><\/span><\/h2>\n<p style=\"text-align: justify;\">\u7a33\u5b9a\u6027\u5206\u6790\u7528\u4e8e\u8bc4\u4f30\u4e13\u5229\u662f\u5426\u5b58\u5728\u65e0\u6548\u7684\u53ef\u80fd\u6027\uff0c\u4e3b\u8981\u4f9d\u636e\u4e3a\u6388\u4e88\u4e13\u5229\u6743\u6240\u5fc5\u5907\u7684\u201c\u4e09\u6027\u201d\uff1a\u65b0\u9896\u6027\u3001\u521b\u9020\u6027\u548c\u5b9e\u7528\u6027\u3002<\/p>\n<p style=\"text-align: justify;\">\u9664\u6ee1\u8db3\u4ee5\u4e0a\u201c\u4e09\u6027\u201d\u5916\uff0c\u8fdb\u884c\u7a33\u5b9a\u6027\u5206\u6790\u65f6\u8fd8\u8981\u8003\u8651\u8be5\u77e5\u8bc6\u4ea7\u6743\u662f\u5426\u5c5e\u4e8e\u6cd5\u5f8b\u89c4\u5b9a\u7684\u53ef\u6388\u6743\u8303\u56f4\u3002\u5176\u6b21\uff0c\u7531\u4e8e\u533b\u836f\u4e13\u5229\u5bf9\u4e8e\u6570\u636e\u7684\u4f9d\u8d56\u6027\u8f83\u5f3a\uff0c\u4e0d\u540c\u5730\u57df\u5bf9\u4e8e\u6570\u636e\u652f\u6301\u6027\u7684\u6807\u51c6\u6709\u5dee\u5f02\uff0c\u4f01\u4e1a\u5e94\u5173\u6ce8\u5b9e\u9a8c\u6570\u636e\u7684\u6709\u6548\u6027\u4ee5\u53ca\u4e0d\u540c\u5730\u57df\u5bf9\u5b9e\u9a8c\u6570\u636e\u3001\u8865\u5145\u5b9e\u9a8c\u6570\u636e\u7684\u63a5\u53d7\u6807\u51c6\u3002\u6700\u540e\uff0c\u4f01\u4e1a\u8fd8\u5e94\u5173\u6ce8\u77e5\u8bc6\u4ea7\u6743\u662f\u5426\u9700\u8981\u5b8c\u6210\u4ee5\u53ca\u80fd\u5426\u6309\u65f6\u5b8c\u6210\u4fdd\u5bc6\u5ba1\u67e5\u3002<\/p>\n<h2 style=\"text-align: justify;\"><span class=\"vantage-red\"><strong>\u4e13\u5229\u5e03\u5c40\u5206\u6790<\/strong><\/span><\/h2>\n<figure id=\"attachment_558522\" aria-describedby=\"caption-attachment-558522\" style=\"width: 200px\" class=\"wp-caption alignright\"><img class=\"wp-image-558522 size-full\" src=\"https:\/\/law.asia\/wp-content\/uploads\/2025\/01\/LI-QIANWEN.png\" alt=\"Li Qianwen\" width=\"200\" height=\"250\" \/><figcaption id=\"caption-attachment-558522\" class=\"wp-caption-text\"><strong>\u674e\u5029\u96ef<\/strong> <br \/>\u5b9e\u4e60\u751f<br \/>\u5e7f\u4fe1\u541b\u8fbe\u5f8b\u5e08\u4e8b\u52a1\u6240<\/figcaption><\/figure>\n<p style=\"text-align: justify;\">\u4e13\u5229\u5e03\u5c40\u5206\u6790\u5219\u662f\u5bf9\u77e5\u8bc6\u4ea7\u6743\u7684\u6280\u672f\u65b9\u6848\u3001\u5730\u57df\u5e03\u5c40\u3001\u540c\u7c7b\u7ade\u54c1\u57fa\u672c\u60c5\u51b5\u3001\u4ea4\u6613\u77e5\u8bc6\u4ea7\u6743\u7684\u524d\u666f\u6027\u8fdb\u884c\u5206\u6790\u3002<\/p>\n<p style=\"text-align: justify;\">\u5bf9\u77e5\u8bc6\u4ea7\u6743\u7684\u5730\u57df\u5e03\u5c40\u5206\u6790\u65f6\uff0c\u9700\u8981\u8003\u5bdf\u6838\u5fc3\u77e5\u8bc6\u4ea7\u6743\u662f\u5426\u5df2\u5728\u4e3b\u8981\u9500\u552e\u5e02\u573a\u3001\u76ee\u6807\u9500\u552e\u5e02\u573a\u4ee5\u53ca\u6f5c\u5728\u62d3\u5c55\u5e02\u573a\u6240\u5728\u56fd\u5bb6\u6216\u5730\u533a\u83b7\u5f97\u4e13\u5229\u4fdd\u62a4\u6216\u5df2\u63d0\u4ea4\u4e13\u5229\u7533\u8bf7\u7b49\u3002<\/p>\n<p style=\"text-align: justify;\">\u5bf9\u77e5\u8bc6\u4ea7\u6743\u6280\u672f\u5e03\u5c40\u5206\u6790\u65f6\uff0c\u9996\u5148\u5e94\u5bf9\u5176\u6280\u672f\u8fdb\u884c\u62c6\u89e3\u548c\u5206\u6790\uff0c\u7ecf\u5206\u6790\u540e\u5982\u6709\u5fc5\u8981\u5219\u901a\u8fc7\u540e\u7eed\u7533\u8bf7\u5bf9\u6838\u5fc3\u6280\u672f\u8fdb\u884c\u5168\u9762\u4e13\u5229\u4fdd\u62a4\u3002\u5bf9\u4e8e\u7b80\u5355\u6613\u6a21\u4eff\u7684\u91cd\u70b9\u6280\u672f\uff0c\u5e94\u8fdb\u884c\u6539\u8fdb\u5e76\u63d0\u9ad8\u6280\u672f\u58c1\u5792\uff0c\u4ee5\u9632\u6b62\u7ade\u4e89\u5bf9\u624b\u6a21\u4eff\u6216\u6284\u88ad\u3002\u5bf9\u4e8e\u4fdd\u62a4\u671f\u9650\u8f83\u77ed\u7684\u6838\u5fc3\u6280\u672f\uff0c\u5219\u53ef\u5c1d\u8bd5\u901a\u8fc7PTA\u5236\u5ea6\u5ef6\u957f\u4e13\u5229\u4fdd\u62a4\u671f\u9650\u3002\u901a\u8fc7\u8fd9\u4e9b\u63aa\u65bd\uff0c\u6784\u5efa\u5b8c\u5907\u7684\u77e5\u8bc6\u4ea7\u6743\u5e03\u5c40\u4fdd\u62a4\u7f51\u3002<\/p>\n<h2 style=\"text-align: justify;\"><span class=\"vantage-red\"><strong>\u6761\u6b3e\u8bbe\u8ba1<\/strong><\/span><\/h2>\n<p style=\"text-align: justify;\">\u5728\u533b\u836f\u8de8\u5883BD\u4ea4\u6613\u4e2d\uff0c\u65e0\u8bba\u91c7\u7528\u8bb8\u53ef\u534f\u8bae\u6a21\u5f0f\u8fd8\u662f\u6df7\u5408\u6a21\u5f0f\uff0c\u4f01\u4e1a\u90fd\u5e94\u91cd\u70b9\u5173\u6ce8\u8bb8\u53ef\u534f\u8bae\u6761\u6b3e\u7684\u8bbe\u8ba1\u3002\u5176\u4e2d\uff0c\u77e5\u8bc6\u4ea7\u6743\u6761\u6b3e\u65e0\u7591\u5c5e\u4e8e\u91cd\u70b9\u6761\u6b3e\uff0c\u5e94\u57fa\u4e8e\u8be6\u5c3d\u7684\u77e5\u8bc6\u4ea7\u6743\u5c3d\u804c\u8c03\u67e5\u6765\u8bbe\u8ba1\u3002\u91cd\u70b9\u5173\u6ce8\u7684\u5185\u5bb9\u5305\u62ec\u77e5\u8bc6\u4ea7\u6743\u7684\u6743\u5c5e\u3001\u8bb8\u53ef\u7c7b\u578b\u3001\u662f\u5426\u5b58\u5728\u5206\u8bb8\u53ef\u7b49\u3002<\/p>\n<p style=\"text-align: justify;\">\u5728\u5904\u7406\u77e5\u8bc6\u4ea7\u6743\u6743\u5c5e\u95ee\u9898\u65f6\uff0c\u53ef\u4ee5\u5c06\u77e5\u8bc6\u4ea7\u6743\u7ea6\u5b9a\u5f52\u5c5e\u4ea4\u6613\u53cc\u65b9\u6240\u6709\uff0c\u53cc\u65b9\u5747\u53ef\u5355\u72ec\u9002\u7528\uff0c\u4f46\u4e0d\u5f97\u672a\u7ecf\u53e6\u4e00\u65b9\u540c\u610f\u6388\u4e88\u7b2c\u4e09\u65b9\u9002\u7528\uff1b\u4e5f\u53ef\u4ee5\u6309\u7c7b\u522b\u5212\u5206\u77e5\u8bc6\u4ea7\u6743\uff0c\u7ea6\u5b9a\u4e0d\u540c\u7c7b\u522b\u5f52\u5c5e\u4e8e\u4e0d\u540c\u65b9\u3002\u53e6\u5916\uff0c\u5bf9\u4e8e\u77e5\u8bc6\u4ea7\u6743\u672a\u6765\u7684\u6539\u8fdb\u6216\u4f18\u5316\uff0c\u53ef\u4ee5\u7ea6\u5b9a\u6539\u8fdb\u65b9\u5728\u4e00\u5b9a\u671f\u9650\u5185\u901a\u77e5\u5bf9\u65b9\uff0c\u82e5\u5bf9\u65b9\u5e0c\u671b\u83b7\u5f97\u6539\u8fdb\u540e\u7684\u77e5\u8bc6\u4ea7\u6743\u8bb8\u53ef\uff0c\u5e94\u652f\u4ed8\u76f8\u5e94\u8d39\u7528\uff0c\u4f46\u4eab\u6709\u4f18\u5148\u8d2d\u4e70\u6743\uff1b\u4ea6\u53ef\u7ea6\u5b9a\u4efb\u4f55\u4e00\u65b9\u6539\u8fdb\u540e\uff0c\u53cc\u65b9\u5747\u53ef\u5e73\u5747\u5206\u914d\u6536\u76ca\u3002\u540c\u65f6\uff0c\u534f\u8bae\u4e2d\u5e94\u660e\u786e\u8bb8\u53ef\u7684\u7c7b\u578b\u3001\u8303\u56f4\u3001\u671f\u9650\uff0c\u5e76\u8003\u8651\u662f\u5426\u5141\u8bb8\u88ab\u8bb8\u53ef\u65b9\u8fdb\u884c\u5206\u8bb8\u53ef\u3002<\/p>\n<p style=\"text-align: justify;\">\u533b\u836f\u4f01\u4e1a\u8de8\u5883BD\u4ea4\u6613\u6d89\u53ca\u8f83\u4e3a\u590d\u6742\u7684\u6d41\u7a0b\u3001\u73af\u8282\uff0c\u77e5\u8bc6\u4ea7\u6743\u5c3d\u804c\u8c03\u67e5\u548c\u6761\u6b3e\u8bbe\u8ba1\u5728\u8be5\u4ea4\u6613\u4e2d\u81f3\u5173\u91cd\u8981\u3002<\/p>\n<hr \/>\n<p style=\"text-align: justify;\"><span class=\"vantage-grey\"><em><strong>\u5e7f\u4fe1\u541b\u8fbe\u5f8b\u5e08\u4e8b\u52a1\u6240\u5408\u4f19\u4eba\u674e\u7ea2\u6885\uff0c\u5b9e\u4e60\u751f\u674e\u5029\u96ef\uff0c<\/strong><\/em><\/span><span class=\"vantage-grey\"><em><strong>\u9ad8\u7ea7\u5408\u4f19\u4eba\u5168\u671d\u6656\u5bf9\u672c\u6587\u4ea6\u6709\u8d21\u732e<\/strong><\/em><\/span><\/p>\n<section class=\"format-info\">\n<p style=\"text-align: justify;\"><strong><img class=\"aligncenter wp-image-181701\" src=\"https:\/\/law.asia\/wp-content\/uploads\/2020\/07\/ETR-Logo.jpg\" alt=\"\" width=\"250\" height=\"161\" srcset=\"https:\/\/law.asia\/wp-content\/uploads\/2020\/07\/ETR-Logo.jpg 600w, https:\/\/law.asia\/wp-content\/uploads\/2020\/07\/ETR-Logo-300x194.jpg 300w\" sizes=\"(max-width: 250px) 100vw, 250px\" \/>\u5e7f\u4fe1\u541b\u8fbe\u5f8b\u5e08\u4e8b\u52a1\u6240<\/strong><br \/>\n\u5e7f\u5dde\u5e02\u5929\u6cb3\u533a\u73e0\u6c5f\u65b0\u57ce\u73e0\u6c5f\u4e1c\u8def6\u53f7<br \/>\n\u5e7f\u5dde\u5468\u5927\u798f\u91d1\u878d\u4e2d\u5fc329\u5c42\u300110\u5c42 \u90ae\u7f16: 510623<br \/>\n\u7535\u8bdd: +86 20 3718 1333<br \/>\n\u4f20\u771f: +86 20 3718 1388<br \/>\n\u7535\u5b50\u4fe1\u7bb1: <a href=\"mailto:1213388010@qq.com\">1213388010@qq.com<\/a> | <a href=\"mailto:13809229057@163.com\">13809229057@163.com<\/a><br \/>\n<a href=\"http:\/\/www.etrlawfirm.cn\">www.etrlawfirm.cn<\/a><\/p>\n<\/section>\n","protected":false},"excerpt":{"rendered":"<p>\u533b\u836f\u4f01\u4e1a\u8de8\u5883\u5546\u52a1\u62d3\u5c55\uff08BD\uff09\u4ea4\u6613\u4e3b\u8981\u6307\u533b\u836f\u4f01\u4e1a\u901a\u8fc7\u6280\u672f\u8bb8\u53ef\u8fdb\u884c\u8d44\u6e90\u6574\u5408\uff0c\u5b9e\u73b0\u4e1a\u52a1\u62d3\u5c55\uff0c\u5305\u62ec\u5bf9\u5916\u8bb8\u53ef\u548c\u5f15\u8fdb\u533b\u836f\u6280<\/p>\n","protected":false},"author":7425,"featured_media":558527,"comment_status":"open","ping_status":"closed","sticky":false,"template":"","format":"standard","meta":{"sfsi_plus_gutenberg_text_before_share":"","sfsi_plus_gutenberg_show_text_before_share":"","sfsi_plus_gutenberg_icon_type":"","sfsi_plus_gutenberg_icon_alignemt":"","sfsi_plus_gutenburg_max_per_row":"","meta-author":"\u674e\u7ea2\u6885\u548c\u674e\u5029\u96ef\uff0c\u5e7f\u4fe1\u541b\u8fbe\u5f8b\u5e08\u4e8b\u52a1\u6240"},"categories":[152007,75,271,63412],"tags":[160660,964,23337,2045,160662,160663,1927,160661],"acf":[],"yoast_head":"<!-- This site is optimized with the Yoast SEO Premium plugin v17.7 (Yoast SEO v17.8) - https:\/\/yoast.com\/wordpress\/plugins\/seo\/ -->\n<meta name=\"description\" content=\"\u533b\u836f\u4f01\u4e1a\u8de8\u5883\u5546\u52a1\u62d3\u5c55\uff08BD\uff09\u4ea4\u6613\u4e3b\u8981\u6307\u533b\u836f\u4f01\u4e1a\u901a\u8fc7\u6280\u672f\u8bb8\u53ef\u8fdb\u884c\u8d44\u6e90\u6574\u5408\uff0c\u5b9e\u73b0\u4e1a\u52a1\u62d3\u5c55\uff0c\u5305\u62ec\u5bf9\u5916\u8bb8\u53ef\u548c\u5f15\u8fdb\u533b\u836f\u6280\u672f\u3002\u8fd9\u7c7b\u4ea4\u6613\u672c\u8d28\u4e3a\u77e5\u8bc6\u4ea7\u6743\u8bb8\u53ef\u4ea4\u6613\uff0c\u5728\u4ea4\u6613\u8fc7\u7a0b\u4e2d\u5e94\u91cd\u89c6\u76f8\u5173\u6cd5\u5f8b\u98ce\u9669\u3002\u77e5\u4ea7\u5c3d\u8c03\u77e5\u8bc6\u4ea7\u6743\u5c3d\u804c\u8c03\u67e5\u662f\u4e3a\u89c4\u907f\u77e5\u8bc6\u4ea7\u6743\u6cd5\u5f8b\u98ce\u9669\u5fc5\u4e0d\u53ef\u5c11\u7684\u6807\u51c6\u73af\u8282\uff0c\u4e3b\u8981\u5305\u62ec\u5bf9\u533b\u836f\u6280\u672f\u77e5\u8bc6\u4ea7\u6743\u57fa\u672c\u60c5\u51b5...\" \/>\n<meta name=\"robots\" content=\"index, follow, max-snippet:-1, max-image-preview:large, max-video-preview:-1\" \/>\n<link rel=\"canonical\" href=\"https:\/\/law.asia\/zh-hans\/pharmaceutical-ip-licensing\/\" \/>\n<meta property=\"og:locale\" content=\"zh_CN\" \/>\n<meta property=\"og:type\" content=\"article\" \/>\n<meta property=\"og:title\" content=\"\u533b\u836f\u8de8\u5883BD\u4ea4\u6613\u4e4b\u77e5\u4ea7\u8bb8\u53ef\u8981\u70b9\" \/>\n<meta property=\"og:description\" content=\"\u533b\u836f\u4f01\u4e1a\u8de8\u5883\u5546\u52a1\u62d3\u5c55\uff08BD\uff09\u4ea4\u6613\u4e3b\u8981\u6307\u533b\u836f\u4f01\u4e1a\u901a\u8fc7\u6280\u672f\u8bb8\u53ef\u8fdb\u884c\u8d44\u6e90\u6574\u5408\uff0c\u5b9e\u73b0\u4e1a\u52a1\u62d3\u5c55\uff0c\u5305\u62ec\u5bf9\u5916\u8bb8\u53ef\u548c\u5f15\u8fdb\u533b\u836f\u6280\u672f\u3002\u8fd9\u7c7b\u4ea4\u6613\u672c\u8d28\u4e3a\u77e5\u8bc6\u4ea7\u6743\u8bb8\u53ef\u4ea4\u6613\uff0c\u5728\u4ea4\u6613\u8fc7\u7a0b\u4e2d\u5e94\u91cd\u89c6\u76f8\u5173\u6cd5\u5f8b\u98ce\u9669\u3002\u77e5\u4ea7\u5c3d\u8c03\u77e5\u8bc6\u4ea7\u6743\u5c3d\u804c\u8c03\u67e5\u662f\u4e3a\u89c4\u907f\u77e5\u8bc6\u4ea7\u6743\u6cd5\u5f8b\u98ce\u9669\u5fc5\u4e0d\u53ef\u5c11\u7684\u6807\u51c6\u73af\u8282\uff0c\u4e3b\u8981\u5305\u62ec\u5bf9\u533b\u836f\u6280\u672f\u77e5\u8bc6\u4ea7\u6743\u57fa\u672c\u60c5\u51b5...\" \/>\n<meta property=\"og:url\" content=\"https:\/\/law.asia\/zh-hans\/pharmaceutical-ip-licensing\/\" \/>\n<meta property=\"og:site_name\" content=\"Law.asia\" \/>\n<meta property=\"article:publisher\" content=\"https:\/\/www.facebook.com\/AsiaBusinessLaw\/\" \/>\n<meta property=\"article:published_time\" content=\"2025-01-22T02:09:24+00:00\" \/>\n<meta property=\"article:modified_time\" content=\"2025-08-25T03:02:53+00:00\" \/>\n<meta property=\"og:image\" content=\"https:\/\/law.asia\/wp-content\/uploads\/2025\/01\/Cross-border-licensing-of-pharmaceutical-IP.jpg\" \/>\n\t<meta property=\"og:image:width\" content=\"900\" \/>\n\t<meta property=\"og:image:height\" content=\"600\" \/>\n<meta name=\"twitter:card\" content=\"summary_large_image\" \/>\n<meta name=\"twitter:creator\" content=\"@ablj_insights\" \/>\n<meta name=\"twitter:site\" content=\"@ablj_insights\" \/>\n<meta name=\"twitter:label1\" content=\"\u4f5c\u8005\" \/>\n\t<meta name=\"twitter:data1\" content=\"Jan\" \/>\n\t<meta name=\"twitter:label2\" content=\"\u9884\u8ba1\u9605\u8bfb\u65f6\u95f4\" \/>\n\t<meta name=\"twitter:data2\" content=\"1 minute\" \/>\n<script type=\"application\/ld+json\" class=\"yoast-schema-graph\">{\"@context\":\"https:\/\/schema.org\",\"@graph\":[{\"@type\":\"Organization\",\"@id\":\"https:\/\/law.asia\/zh-hans\/#organization\",\"name\":\"Law.asia\",\"url\":\"https:\/\/law.asia\/zh-hans\/\",\"sameAs\":[\"https:\/\/www.facebook.com\/AsiaBusinessLaw\/\",\"https:\/\/www.instagram.com\/law.asia_\/?hl=en\",\"https:\/\/www.linkedin.com\/company\/asiabusinesslawjournal\/\",\"https:\/\/www.youtube.com\/@Law.asiaLimited\",\"https:\/\/twitter.com\/ablj_insights\"],\"logo\":{\"@type\":\"ImageObject\",\"@id\":\"https:\/\/law.asia\/zh-hans\/#logo\",\"inLanguage\":\"zh-CN\",\"url\":\"https:\/\/law.asia\/wp-content\/uploads\/2020\/10\/LAWDOTASIA-LOGO-152.png\",\"contentUrl\":\"https:\/\/law.asia\/wp-content\/uploads\/2020\/10\/LAWDOTASIA-LOGO-152.png\",\"width\":152,\"height\":152,\"caption\":\"Law.asia\"},\"image\":{\"@id\":\"https:\/\/law.asia\/zh-hans\/#logo\"}},{\"@type\":\"WebSite\",\"@id\":\"https:\/\/law.asia\/zh-hans\/#website\",\"url\":\"https:\/\/law.asia\/zh-hans\/\",\"name\":\"Law.asia\",\"description\":\"\",\"publisher\":{\"@id\":\"https:\/\/law.asia\/zh-hans\/#organization\"},\"potentialAction\":[{\"@type\":\"SearchAction\",\"target\":{\"@type\":\"EntryPoint\",\"urlTemplate\":\"https:\/\/law.asia\/zh-hans\/?s={search_term_string}\"},\"query-input\":\"required name=search_term_string\"}],\"inLanguage\":\"zh-CN\"},{\"@type\":\"ImageObject\",\"@id\":\"https:\/\/law.asia\/zh-hans\/pharmaceutical-ip-licensing\/#primaryimage\",\"inLanguage\":\"zh-CN\",\"url\":\"https:\/\/law.asia\/wp-content\/uploads\/2025\/01\/Cross-border-licensing-of-pharmaceutical-IP.jpg\",\"contentUrl\":\"https:\/\/law.asia\/wp-content\/uploads\/2025\/01\/Cross-border-licensing-of-pharmaceutical-IP.jpg\",\"width\":900,\"height\":600,\"caption\":\"Pharmaceutical IP Licensing\"},{\"@type\":\"WebPage\",\"@id\":\"https:\/\/law.asia\/zh-hans\/pharmaceutical-ip-licensing\/#webpage\",\"url\":\"https:\/\/law.asia\/zh-hans\/pharmaceutical-ip-licensing\/\",\"name\":\"\\u533b\\u836f\\u8de8\\u5883BD\\u4ea4\\u6613\\u4e4b\\u77e5\\u4ea7\\u8bb8\\u53ef\\u8981\\u70b9 | \\u4e2d\\u56fd | Law.asia\",\"isPartOf\":{\"@id\":\"https:\/\/law.asia\/zh-hans\/#website\"},\"primaryImageOfPage\":{\"@id\":\"https:\/\/law.asia\/zh-hans\/pharmaceutical-ip-licensing\/#primaryimage\"},\"datePublished\":\"2025-01-22T02:09:24+00:00\",\"dateModified\":\"2025-08-25T03:02:53+00:00\",\"description\":\"\\u533b\\u836f\\u4f01\\u4e1a\\u8de8\\u5883\\u5546\\u52a1\\u62d3\\u5c55\\uff08BD\\uff09\\u4ea4\\u6613\\u4e3b\\u8981\\u6307\\u533b\\u836f\\u4f01\\u4e1a\\u901a\\u8fc7\\u6280\\u672f\\u8bb8\\u53ef\\u8fdb\\u884c\\u8d44\\u6e90\\u6574\\u5408\\uff0c\\u5b9e\\u73b0\\u4e1a\\u52a1\\u62d3\\u5c55\\uff0c\\u5305\\u62ec\\u5bf9\\u5916\\u8bb8\\u53ef\\u548c\\u5f15\\u8fdb\\u533b\\u836f\\u6280\\u672f\\u3002\\u8fd9\\u7c7b\\u4ea4\\u6613\\u672c\\u8d28\\u4e3a\\u77e5\\u8bc6\\u4ea7\\u6743\\u8bb8\\u53ef\\u4ea4\\u6613\\uff0c\\u5728\\u4ea4\\u6613\\u8fc7\\u7a0b\\u4e2d\\u5e94\\u91cd\\u89c6\\u76f8\\u5173\\u6cd5\\u5f8b\\u98ce\\u9669\\u3002\\u77e5\\u4ea7\\u5c3d\\u8c03\\u77e5\\u8bc6\\u4ea7\\u6743\\u5c3d\\u804c\\u8c03\\u67e5\\u662f\\u4e3a\\u89c4\\u907f\\u77e5\\u8bc6\\u4ea7\\u6743\\u6cd5\\u5f8b\\u98ce\\u9669\\u5fc5\\u4e0d\\u53ef\\u5c11\\u7684\\u6807\\u51c6\\u73af\\u8282\\uff0c\\u4e3b\\u8981\\u5305\\u62ec\\u5bf9\\u533b\\u836f\\u6280\\u672f\\u77e5\\u8bc6\\u4ea7\\u6743\\u57fa\\u672c\\u60c5\\u51b5...\",\"breadcrumb\":{\"@id\":\"https:\/\/law.asia\/zh-hans\/pharmaceutical-ip-licensing\/#breadcrumb\"},\"inLanguage\":\"zh-CN\",\"potentialAction\":[{\"@type\":\"ReadAction\",\"target\":[\"https:\/\/law.asia\/zh-hans\/pharmaceutical-ip-licensing\/\"]}]},{\"@type\":\"BreadcrumbList\",\"@id\":\"https:\/\/law.asia\/zh-hans\/pharmaceutical-ip-licensing\/#breadcrumb\",\"itemListElement\":[{\"@type\":\"ListItem\",\"position\":1,\"name\":\"Home\"}]},{\"@type\":\"Article\",\"@id\":\"https:\/\/law.asia\/zh-hans\/pharmaceutical-ip-licensing\/#article\",\"isPartOf\":{\"@id\":\"https:\/\/law.asia\/zh-hans\/pharmaceutical-ip-licensing\/#webpage\"},\"author\":{\"@id\":\"https:\/\/law.asia\/zh-hans\/#\/schema\/person\/9faa14703e4a324e69f759a9ed21a8a5\"},\"headline\":\"\\u533b\\u836f\\u8de8\\u5883BD\\u4ea4\\u6613\\u4e4b\\u77e5\\u4ea7\\u8bb8\\u53ef\\u8981\\u70b9\",\"datePublished\":\"2025-01-22T02:09:24+00:00\",\"dateModified\":\"2025-08-25T03:02:53+00:00\",\"mainEntityOfPage\":{\"@id\":\"https:\/\/law.asia\/zh-hans\/pharmaceutical-ip-licensing\/#webpage\"},\"wordCount\":33,\"commentCount\":0,\"publisher\":{\"@id\":\"https:\/\/law.asia\/zh-hans\/#organization\"},\"image\":{\"@id\":\"https:\/\/law.asia\/zh-hans\/pharmaceutical-ip-licensing\/#primaryimage\"},\"thumbnailUrl\":\"https:\/\/law.asia\/wp-content\/uploads\/2025\/01\/Cross-border-licensing-of-pharmaceutical-IP.jpg\",\"keywords\":[\"\\u4e13\\u5229\\u5e03\\u5c40\\u7b56\\u7565\",\"\\u533b\\u836f\",\"\\u5927\\u6e7e\\u533a\",\"\\u5e7f\\u4fe1\\u541b\\u8fbe\\u5f8b\\u5e08\\u4e8b\\u52a1\\u6240\",\"\\u674e\\u5029\\u96ef\",\"\\u674e\\u7ea2\\u6885\",\"\\u77e5\\u8bc6\\u4ea7\\u6743\",\"\\u81ea\\u7531\\u5b9e\\u65bd\\u5206\\u6790\"],\"articleSection\":[\"2024\\u5e7411\\u6708\\u520a\",\"\\u5546\\u6cd5\",\"\\u5546\\u6cd5\\u4e13\\u680f\",\"\\u5e7f\\u4fe1\\u541b\\u8fbe\\u5f8b\\u5e08\\u4e8b\\u52a1\\u6240\"],\"inLanguage\":\"zh-CN\",\"potentialAction\":[{\"@type\":\"CommentAction\",\"name\":\"Comment\",\"target\":[\"https:\/\/law.asia\/zh-hans\/pharmaceutical-ip-licensing\/#respond\"]}],\"copyrightYear\":\"2025\",\"copyrightHolder\":{\"@id\":\"https:\/\/law.asia\/#organization\"}},{\"@type\":\"Person\",\"@id\":\"https:\/\/law.asia\/zh-hans\/#\/schema\/person\/9faa14703e4a324e69f759a9ed21a8a5\",\"name\":\"Jan\",\"image\":{\"@type\":\"ImageObject\",\"@id\":\"https:\/\/law.asia\/zh-hans\/#personlogo\",\"inLanguage\":\"zh-CN\",\"url\":\"https:\/\/secure.gravatar.com\/avatar\/c8044aea04b9ecf97cf9614281fee92c?s=96&d=mm&r=g\",\"contentUrl\":\"https:\/\/secure.gravatar.com\/avatar\/c8044aea04b9ecf97cf9614281fee92c?s=96&d=mm&r=g\",\"caption\":\"Jan\"},\"url\":\"https:\/\/law.asia\/zh-hans\/author\/van_author6\/\"}]}<\/script>\n<!-- \/ Yoast SEO Premium plugin. -->","yoast_head_json":{"description":"\u533b\u836f\u4f01\u4e1a\u8de8\u5883\u5546\u52a1\u62d3\u5c55\uff08BD\uff09\u4ea4\u6613\u4e3b\u8981\u6307\u533b\u836f\u4f01\u4e1a\u901a\u8fc7\u6280\u672f\u8bb8\u53ef\u8fdb\u884c\u8d44\u6e90\u6574\u5408\uff0c\u5b9e\u73b0\u4e1a\u52a1\u62d3\u5c55\uff0c\u5305\u62ec\u5bf9\u5916\u8bb8\u53ef\u548c\u5f15\u8fdb\u533b\u836f\u6280\u672f\u3002\u8fd9\u7c7b\u4ea4\u6613\u672c\u8d28\u4e3a\u77e5\u8bc6\u4ea7\u6743\u8bb8\u53ef\u4ea4\u6613\uff0c\u5728\u4ea4\u6613\u8fc7\u7a0b\u4e2d\u5e94\u91cd\u89c6\u76f8\u5173\u6cd5\u5f8b\u98ce\u9669\u3002\u77e5\u4ea7\u5c3d\u8c03\u77e5\u8bc6\u4ea7\u6743\u5c3d\u804c\u8c03\u67e5\u662f\u4e3a\u89c4\u907f\u77e5\u8bc6\u4ea7\u6743\u6cd5\u5f8b\u98ce\u9669\u5fc5\u4e0d\u53ef\u5c11\u7684\u6807\u51c6\u73af\u8282\uff0c\u4e3b\u8981\u5305\u62ec\u5bf9\u533b\u836f\u6280\u672f\u77e5\u8bc6\u4ea7\u6743\u57fa\u672c\u60c5\u51b5...","robots":{"index":"index","follow":"follow","max-snippet":"max-snippet:-1","max-image-preview":"max-image-preview:large","max-video-preview":"max-video-preview:-1"},"canonical":"https:\/\/law.asia\/zh-hans\/pharmaceutical-ip-licensing\/","og_locale":"zh_CN","og_type":"article","og_title":"\u533b\u836f\u8de8\u5883BD\u4ea4\u6613\u4e4b\u77e5\u4ea7\u8bb8\u53ef\u8981\u70b9","og_description":"\u533b\u836f\u4f01\u4e1a\u8de8\u5883\u5546\u52a1\u62d3\u5c55\uff08BD\uff09\u4ea4\u6613\u4e3b\u8981\u6307\u533b\u836f\u4f01\u4e1a\u901a\u8fc7\u6280\u672f\u8bb8\u53ef\u8fdb\u884c\u8d44\u6e90\u6574\u5408\uff0c\u5b9e\u73b0\u4e1a\u52a1\u62d3\u5c55\uff0c\u5305\u62ec\u5bf9\u5916\u8bb8\u53ef\u548c\u5f15\u8fdb\u533b\u836f\u6280\u672f\u3002\u8fd9\u7c7b\u4ea4\u6613\u672c\u8d28\u4e3a\u77e5\u8bc6\u4ea7\u6743\u8bb8\u53ef\u4ea4\u6613\uff0c\u5728\u4ea4\u6613\u8fc7\u7a0b\u4e2d\u5e94\u91cd\u89c6\u76f8\u5173\u6cd5\u5f8b\u98ce\u9669\u3002\u77e5\u4ea7\u5c3d\u8c03\u77e5\u8bc6\u4ea7\u6743\u5c3d\u804c\u8c03\u67e5\u662f\u4e3a\u89c4\u907f\u77e5\u8bc6\u4ea7\u6743\u6cd5\u5f8b\u98ce\u9669\u5fc5\u4e0d\u53ef\u5c11\u7684\u6807\u51c6\u73af\u8282\uff0c\u4e3b\u8981\u5305\u62ec\u5bf9\u533b\u836f\u6280\u672f\u77e5\u8bc6\u4ea7\u6743\u57fa\u672c\u60c5\u51b5...","og_url":"https:\/\/law.asia\/zh-hans\/pharmaceutical-ip-licensing\/","og_site_name":"Law.asia","article_publisher":"https:\/\/www.facebook.com\/AsiaBusinessLaw\/","article_published_time":"2025-01-22T02:09:24+00:00","article_modified_time":"2025-08-25T03:02:53+00:00","og_image":[{"width":900,"height":600,"url":"https:\/\/law.asia\/wp-content\/uploads\/2025\/01\/Cross-border-licensing-of-pharmaceutical-IP.jpg","type":"image\/jpeg"}],"twitter_card":"summary_large_image","twitter_creator":"@ablj_insights","twitter_site":"@ablj_insights","twitter_misc":{"\u4f5c\u8005":"Jan","\u9884\u8ba1\u9605\u8bfb\u65f6\u95f4":"1 minute"},"schema":{"@context":"https:\/\/schema.org","@graph":[{"@type":"Organization","@id":"https:\/\/law.asia\/zh-hans\/#organization","name":"Law.asia","url":"https:\/\/law.asia\/zh-hans\/","sameAs":["https:\/\/www.facebook.com\/AsiaBusinessLaw\/","https:\/\/www.instagram.com\/law.asia_\/?hl=en","https:\/\/www.linkedin.com\/company\/asiabusinesslawjournal\/","https:\/\/www.youtube.com\/@Law.asiaLimited","https:\/\/twitter.com\/ablj_insights"],"logo":{"@type":"ImageObject","@id":"https:\/\/law.asia\/zh-hans\/#logo","inLanguage":"zh-CN","url":"https:\/\/law.asia\/wp-content\/uploads\/2020\/10\/LAWDOTASIA-LOGO-152.png","contentUrl":"https:\/\/law.asia\/wp-content\/uploads\/2020\/10\/LAWDOTASIA-LOGO-152.png","width":152,"height":152,"caption":"Law.asia"},"image":{"@id":"https:\/\/law.asia\/zh-hans\/#logo"}},{"@type":"WebSite","@id":"https:\/\/law.asia\/zh-hans\/#website","url":"https:\/\/law.asia\/zh-hans\/","name":"Law.asia","description":"","publisher":{"@id":"https:\/\/law.asia\/zh-hans\/#organization"},"potentialAction":[{"@type":"SearchAction","target":{"@type":"EntryPoint","urlTemplate":"https:\/\/law.asia\/zh-hans\/?s={search_term_string}"},"query-input":"required name=search_term_string"}],"inLanguage":"zh-CN"},{"@type":"ImageObject","@id":"https:\/\/law.asia\/zh-hans\/pharmaceutical-ip-licensing\/#primaryimage","inLanguage":"zh-CN","url":"https:\/\/law.asia\/wp-content\/uploads\/2025\/01\/Cross-border-licensing-of-pharmaceutical-IP.jpg","contentUrl":"https:\/\/law.asia\/wp-content\/uploads\/2025\/01\/Cross-border-licensing-of-pharmaceutical-IP.jpg","width":900,"height":600,"caption":"Pharmaceutical IP Licensing"},{"@type":"WebPage","@id":"https:\/\/law.asia\/zh-hans\/pharmaceutical-ip-licensing\/#webpage","url":"https:\/\/law.asia\/zh-hans\/pharmaceutical-ip-licensing\/","name":"\u533b\u836f\u8de8\u5883BD\u4ea4\u6613\u4e4b\u77e5\u4ea7\u8bb8\u53ef\u8981\u70b9 | \u4e2d\u56fd | Law.asia","isPartOf":{"@id":"https:\/\/law.asia\/zh-hans\/#website"},"primaryImageOfPage":{"@id":"https:\/\/law.asia\/zh-hans\/pharmaceutical-ip-licensing\/#primaryimage"},"datePublished":"2025-01-22T02:09:24+00:00","dateModified":"2025-08-25T03:02:53+00:00","description":"\u533b\u836f\u4f01\u4e1a\u8de8\u5883\u5546\u52a1\u62d3\u5c55\uff08BD\uff09\u4ea4\u6613\u4e3b\u8981\u6307\u533b\u836f\u4f01\u4e1a\u901a\u8fc7\u6280\u672f\u8bb8\u53ef\u8fdb\u884c\u8d44\u6e90\u6574\u5408\uff0c\u5b9e\u73b0\u4e1a\u52a1\u62d3\u5c55\uff0c\u5305\u62ec\u5bf9\u5916\u8bb8\u53ef\u548c\u5f15\u8fdb\u533b\u836f\u6280\u672f\u3002\u8fd9\u7c7b\u4ea4\u6613\u672c\u8d28\u4e3a\u77e5\u8bc6\u4ea7\u6743\u8bb8\u53ef\u4ea4\u6613\uff0c\u5728\u4ea4\u6613\u8fc7\u7a0b\u4e2d\u5e94\u91cd\u89c6\u76f8\u5173\u6cd5\u5f8b\u98ce\u9669\u3002\u77e5\u4ea7\u5c3d\u8c03\u77e5\u8bc6\u4ea7\u6743\u5c3d\u804c\u8c03\u67e5\u662f\u4e3a\u89c4\u907f\u77e5\u8bc6\u4ea7\u6743\u6cd5\u5f8b\u98ce\u9669\u5fc5\u4e0d\u53ef\u5c11\u7684\u6807\u51c6\u73af\u8282\uff0c\u4e3b\u8981\u5305\u62ec\u5bf9\u533b\u836f\u6280\u672f\u77e5\u8bc6\u4ea7\u6743\u57fa\u672c\u60c5\u51b5...","breadcrumb":{"@id":"https:\/\/law.asia\/zh-hans\/pharmaceutical-ip-licensing\/#breadcrumb"},"inLanguage":"zh-CN","potentialAction":[{"@type":"ReadAction","target":["https:\/\/law.asia\/zh-hans\/pharmaceutical-ip-licensing\/"]}]},{"@type":"BreadcrumbList","@id":"https:\/\/law.asia\/zh-hans\/pharmaceutical-ip-licensing\/#breadcrumb","itemListElement":[{"@type":"ListItem","position":1,"name":"Home"}]},{"@type":"Article","@id":"https:\/\/law.asia\/zh-hans\/pharmaceutical-ip-licensing\/#article","isPartOf":{"@id":"https:\/\/law.asia\/zh-hans\/pharmaceutical-ip-licensing\/#webpage"},"author":{"@id":"https:\/\/law.asia\/zh-hans\/#\/schema\/person\/9faa14703e4a324e69f759a9ed21a8a5"},"headline":"\u533b\u836f\u8de8\u5883BD\u4ea4\u6613\u4e4b\u77e5\u4ea7\u8bb8\u53ef\u8981\u70b9","datePublished":"2025-01-22T02:09:24+00:00","dateModified":"2025-08-25T03:02:53+00:00","mainEntityOfPage":{"@id":"https:\/\/law.asia\/zh-hans\/pharmaceutical-ip-licensing\/#webpage"},"wordCount":33,"commentCount":0,"publisher":{"@id":"https:\/\/law.asia\/zh-hans\/#organization"},"image":{"@id":"https:\/\/law.asia\/zh-hans\/pharmaceutical-ip-licensing\/#primaryimage"},"thumbnailUrl":"https:\/\/law.asia\/wp-content\/uploads\/2025\/01\/Cross-border-licensing-of-pharmaceutical-IP.jpg","keywords":["\u4e13\u5229\u5e03\u5c40\u7b56\u7565","\u533b\u836f","\u5927\u6e7e\u533a","\u5e7f\u4fe1\u541b\u8fbe\u5f8b\u5e08\u4e8b\u52a1\u6240","\u674e\u5029\u96ef","\u674e\u7ea2\u6885","\u77e5\u8bc6\u4ea7\u6743","\u81ea\u7531\u5b9e\u65bd\u5206\u6790"],"articleSection":["2024\u5e7411\u6708\u520a","\u5546\u6cd5","\u5546\u6cd5\u4e13\u680f","\u5e7f\u4fe1\u541b\u8fbe\u5f8b\u5e08\u4e8b\u52a1\u6240"],"inLanguage":"zh-CN","potentialAction":[{"@type":"CommentAction","name":"Comment","target":["https:\/\/law.asia\/zh-hans\/pharmaceutical-ip-licensing\/#respond"]}],"copyrightYear":"2025","copyrightHolder":{"@id":"https:\/\/law.asia\/#organization"}},{"@type":"Person","@id":"https:\/\/law.asia\/zh-hans\/#\/schema\/person\/9faa14703e4a324e69f759a9ed21a8a5","name":"Jan","image":{"@type":"ImageObject","@id":"https:\/\/law.asia\/zh-hans\/#personlogo","inLanguage":"zh-CN","url":"https:\/\/secure.gravatar.com\/avatar\/c8044aea04b9ecf97cf9614281fee92c?s=96&d=mm&r=g","contentUrl":"https:\/\/secure.gravatar.com\/avatar\/c8044aea04b9ecf97cf9614281fee92c?s=96&d=mm&r=g","caption":"Jan"},"url":"https:\/\/law.asia\/zh-hans\/author\/van_author6\/"}]}},"_links":{"self":[{"href":"https:\/\/law.asia\/zh-hans\/wp-json\/wp\/v2\/posts\/558531"}],"collection":[{"href":"https:\/\/law.asia\/zh-hans\/wp-json\/wp\/v2\/posts"}],"about":[{"href":"https:\/\/law.asia\/zh-hans\/wp-json\/wp\/v2\/types\/post"}],"author":[{"embeddable":true,"href":"https:\/\/law.asia\/zh-hans\/wp-json\/wp\/v2\/users\/7425"}],"replies":[{"embeddable":true,"href":"https:\/\/law.asia\/zh-hans\/wp-json\/wp\/v2\/comments?post=558531"}],"version-history":[{"count":3,"href":"https:\/\/law.asia\/zh-hans\/wp-json\/wp\/v2\/posts\/558531\/revisions"}],"predecessor-version":[{"id":558595,"href":"https:\/\/law.asia\/zh-hans\/wp-json\/wp\/v2\/posts\/558531\/revisions\/558595"}],"wp:featuredmedia":[{"embeddable":true,"href":"https:\/\/law.asia\/zh-hans\/wp-json\/wp\/v2\/media\/558527"}],"wp:attachment":[{"href":"https:\/\/law.asia\/zh-hans\/wp-json\/wp\/v2\/media?parent=558531"}],"wp:term":[{"taxonomy":"category","embeddable":true,"href":"https:\/\/law.asia\/zh-hans\/wp-json\/wp\/v2\/categories?post=558531"},{"taxonomy":"post_tag","embeddable":true,"href":"https:\/\/law.asia\/zh-hans\/wp-json\/wp\/v2\/tags?post=558531"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}